Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC

Conditions:   Stage III Non-small-cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer;   Radiotherapy Side Effect Intervention:   Radiation: Heterogeneously Hypofractionated Radiotherapy Sponsors:   Danish Lung Cancer Group;   Odense University Hospital;   Rigshospitalet, Denmark;   Vejle Hospital;   Herlev Hospital;   Aarhus University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials